Driver-Map Human Genome-Wide Targeted Expression Profiling Kit (24 reactions)
The DriverMap™ Human Genome-Wide Targeted Expression Profiling Assay enables researchers to simultaneously measure the expression level of almost 19,000 human protein-coding genes in a single assay. By combining highly multiplexed RT-PCR amplification with the depth and precision of next-generation sequencing (NGS) quantitation, the Driver-Map assay provides convenient, comprehensive, highly sensitive, and quantitative meas…
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
The DriverMap™ Human Genome-Wide Targeted Expression Profiling Assay enables researchers to simultaneously measure the expression level of almost 19,000 human protein-coding genes in a single assay.
By combining highly multiplexed RT-PCR amplification with the depth and precision of next-generation sequencing (NGS) quantitation, the Driver-Map assay provides convenient, comprehensive, highly sensitive, and quantitative measurement of gene expression from total RNA.
Don’t miss out on critical changes in gene expression. Capture the complete gene expression picture of your with Driver-Map targeted expression profiling kit.
- Easy-to-run, one-tube, single-day expression profiling directly from total RNA from any tissue, cell, or blood samples
- Efficient multiplex RT-PCR amplification for comprehensive profiles with greater detection of low abundant transcripts
- Robust, reproducible data from low-input RNA samples—start with as little as 10 pg total RNA
Brochures
DriverMap Expression Profiling Assay by Cellecta
The DriverMap™ Human Genome-Wide Targeted Expression Profiling Assay enables researchers to simultaneously measure the expression level of almost 19,000 human protein-coding genes in a single assay. By combining highly multiplexed RT-PCR amplification with the depth and precision of next-generation sequencing (NGS) quantitation, the Driver-Map assay provides convenient, comprehensive, highly sensitive, and quantitative measurement of gene expression from total RNA. Donwload this schematic brochure to recieve information on how the DriverMap assay works.
Combining Gene Editing with Functional Analysis to Elucidate Disease Pathways
At AACR 2017, Paul Diehl, Ph.D., Chief Operating Officer, Cellecta, discusses how the company makes use of new technologies such as gene editing and gene synthesis in combination with next-generation sequencing to develop assays enabling researchers to investigate how gene function and gene expression are linked to tumorigenesis. He describes two approaches – loss-of-function screens and targeted RNA expression analysis – that Cellecta has developed to help investigators better understand that relationship.
